### Comment:
Drug that could become the next blockbuster.  Showed results of decreased cardiovascular events.  Cholesterol med.  recent adcom ordered by FDA for evaluation of label expansion (currently just for elevated triglycerides).  16 independent doctors voted 16-0 for label expansion for prevention of cardiovascular events.  FDA deadline for decision Dec 28.  If label expanded likely buy out I bet 2020.

### REPLY:
Neato, thanks!

### END.